PP
OPTN

PDT Partners’s OptiNose OPTN Stock Holding History

PDT Partners’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-920
Closed -$43K – 874
2021
Q2 		$43K Sell
920
-4,040
-81% -$206K ﹤0.01% 776
2021
Q1 		$275K Sell
4,960
-858
-15% -$52.2K 0.02% 639
2020
Q4 		$361K Sell
5,818
-293
-5% -$17.9K 0.02% 509
2020
Q3 		$358K Buy
6,111
+3,449
+130% +$255K 0.02% 520
2020
Q2 		$297K Buy
+2,662
New +$189K 0.02% 523

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

PDT Partners's OPTN Position: Q3 2021 in Review

PDT Partners sold out of OptiNose (OPTN) in Q3 2021, closing a stake of 920 shares — an estimated $43K sold.

PDT Partners first reported a position in OPTN in Q2 2020 and held it in 5 quarters. The position peaked at $361K in Q4 2020. 49 funds tracked by Wall St. Rank hold OPTN as of Q3 2021.

  • PDT Partners reported no remaining OptiNose position as of Q3 2021 after selling out during the quarter.
  • PDT Partners sold 920 OptiNose shares in Q3 2021, an estimated $43K.
  • PDT Partners first reported a position in OptiNose in Q2 2020 and held it in 5 quarters.
  • PDT Partners's OptiNose position peaked at $361K in Q4 2020.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.